ARTICLE | Clinical News
Vigabatrin: Phase I/II data
August 17, 2015 7:00 AM UTC
Top-line data from an open-label, U.S. Phase I/II trial in 4 Tourrette’s disorder patients who were refractory to all other previous treatments showed that 1 patient receiving twice-daily oral vigabat...